NO312587B1 - Fremgangsmåte for fremstilling av 1-butyl-4-piperidinyl- metylamin - Google Patents

Fremgangsmåte for fremstilling av 1-butyl-4-piperidinyl- metylamin Download PDF

Info

Publication number: NO312587B1
Authority: NO; Norway
Prior art keywords: butyl; toluene; mixture; piperidinylmethylamine; reaction
Prior art date: 1996-09-11

Application number

NO19991148A

Other languages

English (en)

Norwegian (no)

Other versions

NO991148D0 (no

NO991148L (no

Inventor

Michael Fedouloff

David William Guest

Gillian Elizabeth Smith

John Bryce Strachan

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-09-11

Filing date

1999-03-10

Publication date

2002-06-03

1999-03-10 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

1999-03-10 Publication of NO991148D0 publication Critical patent/NO991148D0/no

1999-03-10 Publication of NO991148L publication Critical patent/NO991148L/no

2002-06-03 Publication of NO312587B1 publication Critical patent/NO312587B1/no

Links

238000000034 method Methods 0.000 title claims description 15
238000002360 preparation method Methods 0.000 title description 6
SXSSVNBOMMHRRB-UHFFFAOYSA-N (1-butylpiperidin-4-yl)methanamine Chemical compound CCCCN1CCC(CN)CC1 SXSSVNBOMMHRRB-UHFFFAOYSA-N 0.000 title description 2
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 57
238000006243 chemical reaction Methods 0.000 claims description 10
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
239000000203 mixture Substances 0.000 claims description 8
MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-bromobutane Chemical compound CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 claims description 6
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
238000010992 reflux Methods 0.000 claims description 5
239000002904 solvent Substances 0.000 claims description 5
238000002955 isolation Methods 0.000 claims description 4
239000011541 reaction mixture Substances 0.000 claims description 4
238000004519 manufacturing process Methods 0.000 claims description 3
229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
CXWQAPHDSYDHBR-UHFFFAOYSA-N piperidine-4-carboxamide Chemical compound NC(=O)C1CCNCC1.NC(=O)C1CCNCC1 CXWQAPHDSYDHBR-UHFFFAOYSA-N 0.000 claims description 2
239000003960 organic solvent Substances 0.000 claims 1
DPBWFNDFMCCGGJ-UHFFFAOYSA-N 4-Piperidine carboxamide Chemical compound NC(=O)C1CCNCC1 DPBWFNDFMCCGGJ-UHFFFAOYSA-N 0.000 description 5
LSGKMZLPZFPAIN-UHFFFAOYSA-N 1h-indole-3-carboxamide Chemical compound C1=CC=C2C(C(=O)N)=CNC2=C1 LSGKMZLPZFPAIN-UHFFFAOYSA-N 0.000 description 4
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
KVCSJPATKXABRQ-UHFFFAOYSA-N piboserod Chemical compound C1CN(CCCC)CCC1CNC(=O)C(C1=CC=CC=C11)=C2N1CCCO2 KVCSJPATKXABRQ-UHFFFAOYSA-N 0.000 description 4
238000010533 azeotropic distillation Methods 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
238000001816 cooling Methods 0.000 description 3
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 3
WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
239000008346 aqueous phase Substances 0.000 description 2
KMAKOBLIOCQGJP-UHFFFAOYSA-N indole-3-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=CNC2=C1 KMAKOBLIOCQGJP-UHFFFAOYSA-N 0.000 description 2
239000012280 lithium aluminium hydride Substances 0.000 description 2
150000002825 nitriles Chemical class 0.000 description 2
229910052757 nitrogen Inorganic materials 0.000 description 2
239000000047 product Substances 0.000 description 2
PJWZTMATHPXZCW-UHFFFAOYSA-N 1-butyl-n-methylpiperidin-4-amine Chemical compound CCCCN1CCC(NC)CC1 PJWZTMATHPXZCW-UHFFFAOYSA-N 0.000 description 1
RQFUZUMFPRMVDX-UHFFFAOYSA-N 3-Bromo-1-propanol Chemical compound OCCCBr RQFUZUMFPRMVDX-UHFFFAOYSA-N 0.000 description 1
QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
229910010084 LiAlH4 Inorganic materials 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000029936 alkylation Effects 0.000 description 1
238000005804 alkylation reaction Methods 0.000 description 1
AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical group [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
239000003814 drug Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
230000000694 effects Effects 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
238000004508 fractional distillation Methods 0.000 description 1
208000002551 irritable bowel syndrome Diseases 0.000 description 1
239000010410 layer Substances 0.000 description 1
-1 lithium aluminum hydride Chemical compound 0.000 description 1
239000012044 organic layer Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
239000003523 serotonin 4 antagonist Substances 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
239000000758 substrate Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000005292 vacuum distillation Methods 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Hydrogenated Pyridines (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Optical Couplings Of Light Guides (AREA)

NO19991148A 1996-09-11 1999-03-10 Fremgangsmåte for fremstilling av 1-butyl-4-piperidinyl- metylamin NO312587B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9618967.5A GB9618967D0 (en)	1996-09-11	1996-09-11	Pharmaceuticals
PCT/EP1997/005167 WO1998011067A1 (en)	1996-09-11	1997-09-09	Preparation of 1-butyl-4-piperidinylmethylamine

Publications (3)

Publication Number	Publication Date
NO991148D0 NO991148D0 (no)	1999-03-10
NO991148L NO991148L (no)	1999-03-10
NO312587B1 true NO312587B1 (no)	2002-06-03

Family

ID=10799764

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19991148A NO312587B1 (no)	1996-09-11	1999-03-10	Fremgangsmåte for fremstilling av 1-butyl-4-piperidinyl- metylamin

Country Status (29)

Country	Link
US (1)	US6331631B1 (cs)
EP (1)	EP0927163B1 (cs)
JP (2)	JP3748570B2 (cs)
KR (1)	KR100525703B1 (cs)
CN (1)	CN1102927C (cs)
AR (1)	AR008174A1 (cs)
AT (1)	ATE358121T1 (cs)
AU (1)	AU725210B2 (cs)
BR (1)	BR9712014A (cs)
CA (1)	CA2266468C (cs)
CO (1)	CO4930263A1 (cs)
CY (1)	CY2590B2 (cs)
CZ (1)	CZ290932B6 (cs)
DE (1)	DE69737529T2 (cs)
DK (1)	DK0927163T3 (cs)
ES (1)	ES2285732T3 (cs)
GB (1)	GB9618967D0 (cs)
HU (1)	HUP9904155A3 (cs)
IL (1)	IL128785A0 (cs)
NO (1)	NO312587B1 (cs)
NZ (1)	NZ334272A (cs)
PL (1)	PL191373B1 (cs)
PT (1)	PT927163E (cs)
SA (1)	SA97180387B1 (cs)
SI (1)	SI0927163T1 (cs)
TR (1)	TR199900493T2 (cs)
TW (1)	TW432048B (cs)
WO (1)	WO1998011067A1 (cs)
ZA (1)	ZA978087B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9618967D0 (en) *	1996-09-11	1996-10-23	Smithkline Beecham Plc	Pharmaceuticals
US20020091271A1 (en)	1998-07-16	2002-07-11	Smithkline Beecham Plc	Process for the preparation of an indole derivative
GB0211230D0 (en)	2002-05-16	2002-06-26	Medinnova Sf	Treatment of heart failure
CN104557672B (zh) *	2015-01-26	2016-09-21	湖南华腾制药有限公司	一种1位取代哌啶衍生物的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5821904B2 (ja) *	1975-04-04	1983-05-04	住友化学工業株式会社	シンキナメタノ−アントラセンユウドウタイノセイゾウホウホウ
ZA899436B (en) *	1988-12-12	1990-08-29	Ciba Geigy	Piperidine derivatives
AT394715B (de) *	1990-08-14	1992-06-10	Chemie Linz Gmbh	Verfahren zur n-alkylierung von harnstoffen
SG49153A1 (en) *	1991-09-12	1998-05-18	Smithkline Beecham Plc	5-HT4 receptor antagonists
MA22647A1 (fr) *	1991-09-14	1993-04-01	Smithkline Beecham Plc	Procede de preparation d'un ester ou d'un amide d'un nouveau produit .
WO1993018036A1 (en) *	1992-03-12	1993-09-16	Smithkline Beecham Plc	Condensed indole derivatives as 5ht4-receptor antagonists
GB9209687D0 (en) *	1992-05-06	1992-06-17	Smithkline Beecham Plc	Novel process
WO1994008965A1 (en) *	1992-10-16	1994-04-28	Smithkline Beecham Plc	N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists
DE4427836A1 (de) *	1994-08-05	1996-02-08	Hoechst Ag	Verbindungen aus der Reihe der Phosphane, Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE69627323T2 (de) *	1995-05-31	2004-01-15	Nisshin Seifun Group Inc	Indazolderivate mit einer cyclischen aminogruppe
GB9618967D0 (en) *	1996-09-11	1996-10-23	Smithkline Beecham Plc	Pharmaceuticals

1996
- 1996-09-11 GB GBGB9618967.5A patent/GB9618967D0/en active Pending
1997
- 1997-09-04 CO CO97051291A patent/CO4930263A1/es unknown
- 1997-09-09 PT PT97910322T patent/PT927163E/pt unknown
- 1997-09-09 AU AU47764/97A patent/AU725210B2/en not_active Ceased
- 1997-09-09 CN CN97197756A patent/CN1102927C/zh not_active Expired - Fee Related
- 1997-09-09 IL IL12878597A patent/IL128785A0/xx not_active IP Right Cessation
- 1997-09-09 JP JP51328398A patent/JP3748570B2/ja not_active Expired - Fee Related
- 1997-09-09 CZ CZ1999809A patent/CZ290932B6/cs not_active IP Right Cessation
- 1997-09-09 PL PL332088A patent/PL191373B1/pl not_active IP Right Cessation
- 1997-09-09 WO PCT/EP1997/005167 patent/WO1998011067A1/en not_active Ceased
- 1997-09-09 BR BR9712014A patent/BR9712014A/pt active Search and Examination
- 1997-09-09 TR TR1999/00493T patent/TR199900493T2/xx unknown
- 1997-09-09 AR ARP970104108A patent/AR008174A1/es active IP Right Grant
- 1997-09-09 HU HU9904155A patent/HUP9904155A3/hu unknown
- 1997-09-09 AT AT97910322T patent/ATE358121T1/de active
- 1997-09-09 ES ES97910322T patent/ES2285732T3/es not_active Expired - Lifetime
- 1997-09-09 DE DE69737529T patent/DE69737529T2/de not_active Expired - Lifetime
- 1997-09-09 ZA ZA978087A patent/ZA978087B/xx unknown
- 1997-09-09 NZ NZ334272A patent/NZ334272A/xx unknown
- 1997-09-09 DK DK97910322T patent/DK0927163T3/da active
- 1997-09-09 SI SI9730763T patent/SI0927163T1/sl unknown
- 1997-09-09 EP EP97910322A patent/EP0927163B1/en not_active Expired - Lifetime
- 1997-09-09 KR KR10-1999-7001990A patent/KR100525703B1/ko not_active Expired - Fee Related
- 1997-09-09 CA CA002266468A patent/CA2266468C/en not_active Expired - Fee Related
- 1997-09-10 SA SA97180387A patent/SA97180387B1/ar unknown
- 1997-09-10 TW TW086113072A patent/TW432048B/zh not_active IP Right Cessation
1999
- 1999-03-10 NO NO19991148A patent/NO312587B1/no not_active IP Right Cessation
2000
- 2000-08-22 US US09/643,644 patent/US6331631B1/en not_active Expired - Fee Related
2004
- 2004-12-28 JP JP2004380260A patent/JP2005220126A/ja active Pending
2008
- 2008-02-29 CY CY0800005A patent/CY2590B2/xx unknown

Also Published As

Publication number	Publication date
CN1230179A (zh)	1999-09-29
PL191373B1 (pl)	2006-05-31
HUP9904155A2 (hu)	2000-05-28
US6331631B1 (en)	2001-12-18
DE69737529T2 (de)	2008-01-31
SA97180387B1 (ar)	2006-11-04
HK1020963A1 (en)	2000-05-26
DE69737529D1 (de)	2007-05-10
DK0927163T3 (da)	2007-08-06
KR20000038041A (ko)	2000-07-05
JP3748570B2 (ja)	2006-02-22
NO991148D0 (no)	1999-03-10
CZ290932B6 (cs)	2002-11-13
ATE358121T1 (de)	2007-04-15
NO991148L (no)	1999-03-10
HUP9904155A3 (en)	2001-01-29
EP0927163A1 (en)	1999-07-07
EP0927163B1 (en)	2007-03-28
CO4930263A1 (es)	2000-06-27
CA2266468C (en)	2005-10-25
CY2590B2 (en)	2009-11-04
ZA978087B (en)	1999-03-09
CZ80999A3 (cs)	1999-11-17
GB9618967D0 (en)	1996-10-23
SI0927163T1 (sl)	2007-08-31
JP2005220126A (ja)	2005-08-18
AU4776497A (en)	1998-04-02
PL332088A1 (en)	1999-08-30
WO1998011067A1 (en)	1998-03-19
TR199900493T2 (xx)	1999-06-21
KR100525703B1 (ko)	2005-11-03
CN1102927C (zh)	2003-03-12
TW432048B (en)	2001-05-01
BR9712014A (pt)	1999-08-24
AU725210B2 (en)	2000-10-05
JP2001500148A (ja)	2001-01-09
IL128785A0 (en)	2000-01-31
CA2266468A1 (en)	1998-03-19
ES2285732T3 (es)	2007-11-16
AR008174A1 (es)	1999-12-09
PT927163E (pt)	2007-07-06
NZ334272A (en)	2000-08-25

Legal Events

Date	Code	Title	Description
2012-04-30	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO178260B (no)	1995-11-13	Indolderivater, mellomproduktforbindelser for deres fremstilling, anvendelse derav samt farmasöytisk preparat
GB2124210A (en)	1984-02-15	Indoles
NO137440B (no)	1977-11-21	Analogifremgangsm}te for fremstilling av terapeutisk aktive pleuromutiliner
IE930475A1 (en)	1993-12-29	Process for the preparation of¹N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propylamine¹and acid addition salts thereof
NO312587B1 (no)	2002-06-03	Fremgangsmåte for fremstilling av 1-butyl-4-piperidinyl- metylamin
FI98811C (fi)	1997-08-25	Menetelmä immuunijärjestelmään vaikuttavien bentseenijohdannaisten valmistamiseksi
NO311574B1 (no)	2001-12-10	Fremgangsmåte for fremstilling av N-[(1-n-butyl-4- piperidinyl)metyl]-3,4-dihydro-2H-[1,3]oksazino[3,2-a]indol-10-karboksamid og salter derav, og mellomprodukter som anvendes ifremgangsmåten
NO115944B (cs)	1968-12-30
NO145138B (no)	1981-10-12	Fremgangsmaate for fremstilling av benz(f)-2,5-oksazociner
US20030114684A1 (en)	2003-06-19	Process for the preparation of an indole derivative
EP0135927B1 (en)	1988-07-06	Antihyperlipidemic n-benzoylsulfamates, n-benzylsulfamates and benzylsulfonamides, a therapeutic composition containing same and a process for the production thereof
EP1097135B1 (en)	2008-05-07	Process for the preparation of an indole derivative
EP1097136B1 (en)	2003-10-22	Process for the preparation of an indole derivative
HK1020963B (en)	2007-12-14	Preparation of 1-butyl-4-piperidinylmethylamine
NO153134B (no)	1985-10-14	Fremgangsmaate ved fremstilling av et karbazolderivat
NO162461B (no)	1989-09-25	Fremgangsm te for fremstilling av aminderivater.
SU656511A3 (ru)	1979-04-05	Способ получени производных гексагидро-4-индолинола или их солей
NO131835B (cs)	1975-05-05
NO309767B1 (no)	2001-03-26	Ny form av (E)-3-[6-[[(2,6-diklorfenyl)-tio]metyl]-3-(2- fenyletoksy)-2-pyridinyl]-2-propensyre, anvendelse derav og farmasöytisk blanding inneholdende den
NO145097B (no)	1981-10-05	Analogifremgangsmaate for fremstilling av farmakologisk aktive difenylpropylaminer
NO851399L (no)	1985-10-07	Fremgangsmaate ved fremstilling av terapeutisk aktive fenylidol-derivater.
NO154669B (no)	1986-08-18	Analogifremgangsmaate for fremstilling av terapeutisk aktiv 10-bromsandwicin og 10-bromisosandwicin, samt syreaddisjonssalter derav.
NO781792L (no)	1978-11-27	Fremgangsmaate for fremstilling av n-(3`-fenyltiopropyl)-3,3-difenylpropylamin